Replies to post #108785 on Avid Bioservices Inc (CDMO)

[freethemice]

Yes, here is the data from the poster. There were still 4 more patients left to enroll. Note the percentages for Gem + Bavi.
They are quite different from the ECOG 0/1 50%/50% in the phase II Abraxane trial.

[asmarterwookie]

Thanks sunstar and FTM...All the talk over the Pancreatic trial and when patients were enrolled and this poster was there the whole time!?!?!

"One patient on Bavituximab and Gemcitabine had a durable response lasting 5.8 months and continue survival follow-up as of 12.7 months"

Abstract from June 18-21, 2012.

I hope the patient is still with us!!!!

Now that's a tidbit of BEST DATA!!!

wook

[asmarterwookie]

Top of the board..Thanks again Sunstar and FreetheMice

http://www.peregrineinc.com/images/stories/pdfs/pancreatic_2012_aacr_poster.pdf

wook